Mesothelioma Cancer Resources Blog
-
Protein Can be Reliable for Diagnosing Malignant Mesothelioma
CD146, a protein molecule, has been linked to the advanced tumor stage of various malignant cancers including prostate cancer, ovarian cancer and malignant melanoma. Now scientists have found an increased presence of the protein in malignant mesothelioma, but not in non-cancerous pleural effusions. Researchers reported in an article in Modern Pathology that this distinction may offer …
Label: Research News
Posted on Tuesday, Aug 31, 2010 -
Biomarker Successes Remain Elusive For Mesothelioma and Cancer Researchers
by Nancy Meredith According to the National Cancer Institute, a biomarker is “a biological molecule found in blood, other body fluids, or tissues that is a sign of a normal or abnormal process, or of a condition or disease.” Biomarkers can be useful in diagnosing and treating diseases such as mesothelioma and other cancers, and …
Label: Featured Story
Posted on Monday, Aug 30, 2010 -
Avastin May Not be Effective for Breast Cancer, But is Still an Option for Mesothelioma
In a rare move, the United States Food and Drug Administration may remove their approval for the use of Avastin in the treatment of breast cancer. A 13 member panel of experts reviewed follow-up data on how patients have done on the drug and concluded that the benefits of the drug do not outweigh the …
Label: Treatment News
Posted on Friday, Aug 27, 2010
Mike is a licensed attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly. He has contributed numerous articles to the North Carolina State Bar Journal and is a co-author of Capital Lawyers, a history of the Wake County (NC) Bar.
Gregory Froom is a licensed North Carolina attorney and the former editor of North Carolina Lawyers Weekly and South Carolina Lawyers Weekly.